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ABSTRACT 25 
 The cytokine is one of the proteins responsible for the immune system. Several types of 26 
cytokines acting as key regulators of infection include IL-10, IL-12, and IL-14. The chemical content 27 
of Zingiber cassumunar shows potential immunomodulatory effects. This study aimed to determine 28 
the effect of the ethanol extract of Zingiber cassumunar (EEZC) on the expressions of IL-10, IL-12, 29 
and IL-14. The test animals were BALB/c mice, which were divided into five groups, i.e., normal 30 
group (untreated), negative control group (treated with 10% of tween 80), and three treatment groups 31 
that respectively received 1.25 mg, 2.5mg, and 5mg/20g BW of EEZC. The treatment was carried out 32 
for 21 days. On the 22nd day, the mice were induced with LPS intraperitoneally (except for the normal 33 
group). The interleukin expression was observed by immunohistochemistry using specific antibodies, 34 
and the expressed cells were counted under a microscope. The administration of EEZC at the doses 35 
of 1.25 mg, 2.5mg, and 5mg/20g BW for 21 days increased the expression of IL-10, IL-12, and IL-36 
14 significantly and proportionally to the dose. and suggested the potency of extract to induce both 37 
innate and adaptive immunity. This activity may be attributable to curcumin as an active compound 38 
in this extract. 39 
 40 
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 42 
INTRODUCTION 43 
The immune system is responsible for protecting the host from various pathogenic 44 
microorganisms. At the same time, it functions as a control of immune responses and prevents over-45 
reaction to the body’s own cells (Saraiva and O’Garra, 2010). A decrease in the immune system can 46 
affect the body's strength to fight infections or other diseases. Therefore, the presence of 47 
immunomodulator compound that can improve the immune response to disease or infection is 48 
necessary. 49 
Immunomodulator could be defined as a substance, which can stimulate, suppress or modulate 50 
any of the components of the immuno system including both specific and nonspecific immune system 51 
(Das et al., 2014).  Modulation of the immune system was remarked by induction, expression, 52 
amplification or inhibition of certain part in the immune signaling and response. Thus, 53 
immunomodulator is a substance used for its effect on the immune system.    54 
Interleukin-10 (IL-10) is an anti-inflammatory cytokine that has a crucial role in preventing 55 
inflammatory and autoimmune pathologies. It can both impede pathogen clearance and ameliorate 56 
immunopathology. Many different types of cells can produce IL-10, with the major source of IL-10 57 
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varying in different tissues or during acute or chronic stages of the same infection (Couper et al., 58 
2008). IL-10 has a central role in infection by limiting the immune response to pathogens and thereby 59 
preventing damage to the host.The production of IL-10 was associated with regulatory T (Treg) cells.  60 
(Saraiva and O’Garra, 2010). 61 
Interleukin-12 is an important cytokine in immunoregulation produced mainly by antigen-62 
presenting cells (APC), including macrophages and dendritic cells that respond to microbes (Abbas 63 
et al., 2017). During the immune response, IL-12 is produced as a reaction to stimuli of various 64 
compounds (including lipopolysaccharide/LPS).  65 
Interleukin-14 (IL-14) is one of the cytokines produced by the immune system. It is produced 66 
by activated B cells and T cells (Leca et al., 2008).  The role of IL-14 is to regulate B-cell proliferation. 67 
IL-14 can increase antibody responses to vaccinations causing autoimmunity and contribute to B-cell 68 
lymphoma formation (Shen et al., 2006).  69 
Zingiber cassumunar, known locally as bengle (Javanese, Indonesia), has been used for 70 
treating various diseases traditionally. Z. cassumunar belongs to Zingiberaceae family and contains 71 
terpenoids, essential oil, and curcuminoids. Several studies on Z.cassumunar reported some activities 72 
including anticancer (Varalakshmi et al., 2008), antioxidant (Vankar et al., 2006) (Bua-in and 73 
Paisooksantivatana, 2009) and immunomodulator (Nurkhasanah et al., 2017; Rahmawati, 2013). This 74 
plant has been reported to exhibit an immunomodulatory activity by increasing phagocytic activity in 75 
vitro (Chairul et al., 2009), increasing of nitric oxide and reactive oxygen species (Nurkhasanah et 76 
al., 2017) and decreasing of malondialdehyde product in Plasmodium berghei-infected mice  77 
(Nurmasari et al., 2014).  78 
This study presents the activity of ethanol extract of Zingiber cassumunar (EEZC) in 79 
stimulating the immune response in vivo as observed from its effect on interleukin-10, -12 and -14. 80 
The present study will focus on these cytokines due to the important function of these cytokine in the 81 
immune respons, either innate and adaptive immunity. The expression IL-10 and IL-14 are close 82 
related to activation of adaptive immunity while the IL-12 is important in cell communication 83 
between the macrophage and T cells. The study was carried on Balb/c male mice for 28 days treatment 84 
and through oral administration. This in vivo study provides evidence of higher effectiveness of EEZC 85 
in increasing immune response. This evidence was important information for development of  Z. 86 
cassumunar to be an immunomodulatory product.  87 
 88 
MATERIALS AND METHODS 89 
Materials 90 
The Zingiber cassumunar rhizome was collected from a local market in Yogyakarta and 91 
identified in the Biology Laboratory, Universitas Ahmad Dahlan. The test animal was obtained from 92 
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the Animal House of the Integrated Research and Testing Laboratory, Universitas Gadjah Mada 93 
(LPPT UGM) Yogyakarta, Indonesia. 94 
 95 
Extraction 96 
The rhizome was selected, washed, and then sliced. The sliced rhizome was dried in an oven 97 
at a temperature of 50oC. Afterward, the dried rhizome was blended or ground into powder. The 98 
extraction was carried out by maceration method using  96% ethanol as the solvent. The maceration 99 
lasted for 24 hours, and the yield were evaporated in a vacuum rotary evaporator to obtain a 100 
concentrated extract. The concentrated extract was used for treatment and designated as EEZC. 101 
 102 
Thin-layer Chromatography (TLC) analysis of the extract 103 
The TLC analysis was carried out to identify the active compound of EEZC. A total of 100.0 104 
mg of EEZC was dissolved in 10.0 ml of absolute ethanol. This procedure used curcuminoids (Sigma) 105 
that was dissolved in ethanol as a standard. Each 2 μL of the extract and curcuminoid were applied 106 
on silica gel GF 254 as the stationary phase and eluted with the mobile phase of chloroform: ethanol: 107 
glacial acetic acid (94: 5: 1). The detection of active compound was done under daylight and UV 254 108 
nm. 109 
 110 
Animal treatment 111 
The procedure of the study and the use of test animal were ethically approved by the Research 112 
Ethics Committee of Ahmad Dahlan University on February 9, 2016, with Reference No. 011601011. 113 
The test animals, i.e., BALB/c mice (8 weeks), were acclimatized for a week before the 114 
treatment. The mice were divided into five (5) groups, namely normal group, negative control group 115 
which treated with the solven (solution of tween 80 10%), and 3 treatment groups (1.25 mg/20gBW; 116 
2.5 mg/20gBW; 5 mg/20gBW). The administration of EEZC was carried out orally for 21 days (3 117 
weeks), once a day. On the 22nd day, the mice were sacrificed using CO2 gas. Following sacrificing, 118 
lipopolysachcharide (LPS) (Sigma) with dose 0.01 mg/20 g BW was injected into the peritoneal 119 
cavity area, and after 1 hour, the macrophage was isolated and the expression of interleukin-10, -12 120 
and -14 was observed with immunohistochemistry methode using specific antibody of IL-10, IL-12 121 
and IL-14. 122 
 123 
Macrophage isolation 124 
Following the 21-day treatment, the mice were injected with LPS in the intraperitoneal cavity. 125 
Then, the mice were dissected by opening the skin in the peritoneal area. As much as 10 ml of Roswell 126 
Park Memorial Institute (RPMI) (Sigma) medium was injected into the stomach. The stomach was 127 
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massaged, then the RPMI medium was drawn again. The medium was centrifuged for 10 minutes, 128 
and the supernatant was removed. The macrophage was washed with the medium and incubated for 129 
24 hours. After overnight incubation, the macrophage was harvested. 130 
 131 
Immunohistochemistry assay 132 
The immunohistochemistry assay was based on the method reported in a previous study 133 
(Nurkhasanah, 2015). The method was based on indirect method using specific primary antibody and 134 
was conjugated with secondary antibody and chromogen. The interleukin expressed was observed as 135 
brown colour as product of DAB (dimethyl amino benzidine) chromogen and detected under light 136 
microscope. 137 
The cultured macrophage was fixed with 1 ml of methanol. The methanol was removed, and 138 
the macrophage was washed in PBS (phosphate buffer saline) for 5 minutes. The preparation was 139 
then immersed in peroxidase blocking solution for 10 minutes at room temperature. Afterward, it was 140 
washed under running water and then with PBS. A total of 50µl of blocking serum was added to the 141 
preparation and then incubated in a humid temperature for 10-15 minutes. Then, 100µl (with dilution 142 
1:100) of specific antibody (anti-IL-10, anti-IL-12, and anti-IL-14, murine recombinant, Biovision) 143 
was added to the preparation and incubated on a moist tray at room temperature for 1 hour. After the 144 
incubation, the preparations were washed with 1 mL of PBS. A total of 50 µl (with dilution 1:100) of  145 
antimouse biotin secondary antibody (Biovision) was added to each preparation, which was incubated 146 
at a humid temperature for 20 minutes and then washed with PBS. 147 
The preparations were incubated with 50 μl of the streptavidin-peroxidase enzyme for 10 148 
minutes, washed with PBS, and incubated with 50 µl of DAB chromogen (peroxidase substrate 149 
solution). Afterward, the preparations were washed with PBS and incubated with Mayer’s 150 
hematoxylin as the counterstain. The process was followed by washing with PBS. The macrophage 151 
was ready for microscopic observation at 400x magnification. Macrophages that expressed 152 
interleukin would show as brown stains.  153 
The observation was carried out in some of field of view. The number of positive cell 154 
expression was compared with the whole cell observed and presented as percentage value. The result 155 
of treated group was compared with control group with statistical analysis to analyze the effect of 156 
treatment. 157 
 158 
Statistical analysis 159 
The quantitative data of percentage expression of IL-10, IL-12 and IL-14 was analyze statistically for 160 
normality and homogeneity. The analysis was followed with variance analysis using ANOVA and 161 
followed by LSD for analysis between group of treated. 162 
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 163 
RESULTS AND DISCUSSION 164 
Extraction  165 
The ethanol extract of Zingiber cassumunar rhizome was dark brown with a specific odor, 166 
thick consistency, and slightly bitter taste. The extraction process produced 25.55% yield. This result 167 
has met the standard of the Indonesian Herbal Pharmacopoeia (Depkes RI, 2008). The curcumin 168 
content was detected in the extract, as shown in Figure 1. While curcumin was found to be a major 169 
content in the extract, the other curcumin derivates (i.e., demethoxycurcumin and 170 
bisdemethoxycurcumin) were not detected. 171 
Curcumin is one of major chemical content in EEZC. Curcumin reported to have 172 
immunomodulatory  activity (Varalakshmi et al., 2008). Previous study reported the significantly 173 
increase of  IL-12 levels in curcumin-treated animals on day 10 and 20, after treatment. It is also 174 
found that curcumin induce generation of ROS which important in the immune respon  (Varalakshmi 175 
et al., 2008). Curcuminoid (cassumunin A and cassumunin B) isolated from Z. cassumunar was found 176 
to have a protective effect on living cells suffering from oxidative stress (Nagano et al., 1997). 177 
Beside curcumin, essential oil is also reported is one of main compound in Zingiber 178 
cassumunar rhizome. The highly essential oil content give specific odor of Z. cassumunar rhizome 179 
and extract. Several studies of phytochemical compounds and biological activity of Z. cassumunar 180 
Roxb had been reported the main component of Z. cassumunar rhizome essential oil were 181 
triquinacene 1,4-bis (methoxy), (Z)-ocimene and terpinen-4-ol (Bua-in and Paisooksantivatana, 182 
2009).  The previous studies on  its rhizome also found several phenylbutenoid compounds, 183 
curcuminoid, and sesquiterpene (zerumbon) (Nakamura et al., 2009).  184 
 185 
   186 
Figure 1. The TLC profile of curcuminoids standard (a) and Zingiber cassumunar ethanolic extract 187 
(b), detected in daylight (A) and UV 254 nm (B).    188 
  189 
 190 
A B 
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Expression of IL-10 191 
Indirect immunocytochemistry was employed to detect the expression of interleukin in the 192 
macrophage. The specific antibody of IL-10 interacted with interleukin-10 in the cells and attached 193 
to the secondary antibody. During the detection process, the secondary antibody attached to DAB as 194 
the chromogen, and the expression appeared as brown stains on the cytoplasm area. Meanwhile, the 195 
cells with negative expression appeared in blue as the result of counterstaining. The 196 
immunocytochemistry of the macrophage is shown in Figure 2. The percentage of the IL-10 197 
expression is shown in Table 1. 198 
 199 
 200 
Figure 2 The immunocytochemistry of IL-10 expression in macrophage cells after treatment with 201 
ethanol extract of Zingiber cassumunar which observed with 400x magnification (a) 202 
macrophage with no expression of interleukin (b), macrophage with positive expression of 203 
interleukin 204 
 205 
Table 1 The percentage of IL-10 expression on the macrophage cells of BALB/c mice treated with 206 
ethanol extract of Zingiber cassumunar.  207 
Groups Mean ± SD 
Normal 
Negative control 
Treatment Dose of 1.25mg/20gBW 
Treatment Dose of 2.5mg/20gBW 
Treatment Dose of 5mg/20gBW 
45.65 ± 1.92%* 
51.86 ± 1.42% 
55.91 ± 3.07% 
63.68 ± 2.93%* 
68.65 ± 4.42%* 
*significant difference with negative control (p<0.05) 208 
 209 
The treatment of ethanol extract of Zingiber cassumunar increased the expression of IL-10, 210 
affirming the potential of EEZC as an immunomodulator. IL-10 was expressed by macrophages and 211 
other dendritic cells (DC) as a response to microbial infection. The increase of IL-10 expression may 212 
be attributable to the activation of extracellular signal-regulated kinase 1 (ERK1) and ERK2 (Saraiva 213 
and O’Garra, 2010). Such an increase will activate the specific response of the immune system and 214 
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inhibit the nonspecific response. IL-10 has been identified as an inhibitor of the synthesis of 215 
inflammatory mediators and pro-inflammatory cytokines that play a role in modulating fever and 216 
sickness (Harden et al., 2013). The present study also found that the expression of IL-10 in negative 217 
control group increased significantly compared to normal, which could be caused by the tween 80 218 
effect. The previous study also reported that polysorbate (tween) 80 could increase the immune 219 
response (Maggio, 2012). 220 
The increased expression of IL-10 was proportional to the administered dose. The higher the 221 
treatment dose, the higher the expression of IL-10 was. However, an extremely high level of IL-10 222 
can inhibit chemokine production and prevent its role in directing lymphocytes to the lymph nodes, 223 
as in mycobacterial infection, resulting in a failure to recruit and induce Th1 cell differentiation 224 
(Couper et al., 2008). Therefore, IL-10 has both immunosuppressive and immunostimulatory 225 
properties (Acuner-ozbabacan et al., 2014).  226 
The regulation of IL-10 expression involves the enhancement or silencing of IL10 transcription 227 
and is regulated by certain transcription factors activated by discrete signal-transduction pathways. 228 
Following transcription, the post-transcriptional mechanisms exist and involeves many of the 229 
molecular events leading to IL-10 expression (Saraiva and O’Garra, 2010). Some molecule of 230 
Zingiber cassumunar could be involves and affect the transcriptional process of IL-10 and leading on 231 
increasing level of IL-10.   232 
 233 
Expression of Interleukin-12 234 
Interleukin-12 (IL-12) is a pro-inflammatory cytokine that induces the production of interferon-235 
γ (IFN-γ), and leading to  the differentiation of T helper 1 (TH1) cells and connected the link of innate 236 
immunity and adaptive immunity. Dendritic cells (DCs) and macrophages produce IL-12 in response 237 
to pathogens and infection (Trinchieri, 2003). Production of IL-12 is strongly regulated by positive 238 
and negative regulatory mechanisms. Microorganism products including bacteria, intracellular 239 
parasites, fungi, double-stranded RNA, bacterial DNA and oligonucleotides are strong inducers of 240 
IL-12 production by macrophages, monocytes, neutrophils and DCs. The LPS was used in this study 241 
to activate the macrophage to produce the IL-12.  The quantitative analysis of the expression of IL-242 
12 after the administration of EEZC is shown in Table 2. 243 
 244 
Table 2 The expression of IL-12 in macrophage cells of BALB/c mice treated with ethanol extract of 245 
Zingiber cassumunar  246 
Groups Mean ± SD 
Normal 64.63% ± 9.763 
Negative Control 66.39% ± 1.603 
Treatment Dose of 1.25mg/20g BW 51.56% ± 4.528* 
Treatment Dose of 2.5mg/20g BW 70.62% ± 3.469 
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Treatment Dose of 5mg/20g BW 77.00% ± 5.110* 
*) significant difference with negative control (p<0.05)  247 
 248 
The study found that the IL-12 expression in the negative control group was not significantly 249 
different from the normal group, indicating that the solvent (tween 80) does not affect the immune 250 
response.  Tween 80 could stimulate the immunogenicity (Maggio, 2012) as shown by the increasing 251 
of IL-10 in the present study. But the dose used in this study is not enough to increase the IL-12 252 
expression. The treatment of EEZC at a dose of 1.25mg/20g BW induced lower IL-12 expression 253 
than the negative control. In other words, the lower the dose, the less effective the active compound 254 
of EEZC in increasing the IL-12 expression. When the dose increased, the IL-12 expression was also 255 
found to be elevated.  256 
 The immunomodulatory effects of EEZC might be caused by the presence of curcumin as an 257 
active compound. Curcumin has been reported to increase the immune response of the cells (Nagano 258 
et al., 1997; Nurkhasanah et al., 2017). The previous study also found that curcumin treatment 259 
elevated the IL-12 level in mice (Varalakshmi et al., 2008). The increasing level of IL-12 in the 260 
treatment could be caused by the capacity of curcumin in increasing of ROS and NO (Nurmasari et 261 
al., 2014; Rahmawati, 2013). ROS is known to regulate the IL-12 generation. Another studies have 262 
revealed that curcumin stimulates T cell, B cell, neutrophil, NK cell, and dendritic cell (Nurmasari et 263 
al., 2014). 264 
The essential oil, which emitted a special odor, was also identified in EEZC (Bhuiyan et al., 265 
2008). The presence of essential oils in EEZC has also been reported to boost the immune response, 266 
including the phagocytic activity of macrophages (Chairul et al., 2009; Nakamura et al., 2009). The 267 
active compound from volatile oil which successfully identified as immunomodulatory compound 268 
are phenilbutenoids compound (Chairul et al., 2009). 269 
 The treatment of EEZC increased IL-12 expression, activating T cells and stimulating the 270 
production of IFN-γ, which lead to macrophage activation and the secretion of reactive oxygen 271 
species (ROS) that eliminate infections (Abbas et al., 2017). Furthermore, this treatment can intensify 272 
the phagocytic activity of macrophage (Nurkhasanah et al., 2017). 273 
  274 
Expression of Interleukin-14 275 
IL-14 was first known as a high-molecular-weight B-cell growth factor and originally 276 
identified as a B cell growth factor (Shen et al., 2006). It is produced by T cells and B-cells. IL-14 277 
binds and signals through a 90-kDa receptor expressed on activated B cells to promote B-cell 278 
proliferation (Akdis et al., 2016). High level of IL-14 can enhance B-cell proliferation and expand a 279 
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subpopulation of memory B cells  (Leca et al., 2008), and if followed by the secretion of antibody, it 280 
can eliminate the invader. The expression of IL-14 in EEZC-treated mice is shown in Table 3. 281 
  282 
Table 3 The expressions of Interleukin-14 in mice treated with ethanol extract of Zingiber 283 
cassumunar  284 
Groups Expressions (X ± SD)  
Normal 59.19 ± 3.07% 
Negative control 61.24 ± 1.51% 
Treatment Dose of 1.25 mg/20g BW 57.02 ± 1.94%* 
Treatment Dose of 2.5 mg/20g BW 67.41  ± 6.60% 
Treatment Dose of 5 mg/20g BW  71.07 ± 1.30%* 
(*) showed significant difference with negative control (p<0.05) 285 
 286 
The previous research proposes increasing the expression of IL-14 by the treatment of some 287 
herbal medicine extract (Nurkhasanah, 2015). The treatment of anthocyanin-rich rosella extract 288 
increases the IL-10 and IL-14 expressions in vitro. The present research also found that the treatment 289 
of EEZC increased the IL-10, IL-12, and IL-14 expressions after LPS induction. This induction 290 
stimulated the immune response because LPS was recognized as endotoxin consisting of a lipid   and 291 
a polysaccaride   found on the outer membrane of gram-negative bacteria. The activity of EEZC in 292 
increasing of IL-10, IL-12 and IL-14 suggested the potency of this extract in inducing the immune 293 
system in both innate and adaptive immunity. 294 
A previous study on Zingiberaceae family, including Curcuma mangga, Kaempferia 295 
angustifolia, and Zingiber cassumunar, highlights that Zingiber cassumunar has the highest 296 
immunomodulatory activity (Chairul et al., 2009), which may be caused by the active compound of 297 
curcumin and essential oil. The major compound found in Z. cassumunar essential oil was phenyl 298 
butanoic compound. Furthermore, a toxicity study states that Zingiber cassumunar extract has no 299 
observable adverse effect and it is well-tolerated for both acute and chronic studies (Koontongkaew 300 
et al., 2014).  301 
 302 
CONCLUSION 303 
The ethanol extract of Zingiber cassumunar has immunomodulatory activity through increasing 304 
level of IL-10, IL-12 and IL-14 cytokines and suggested the potency of extract to induce both innate 305 
and adaptive immunity. 306 
 307 
 308 
 309 
 310 
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